Chronic kidney disease is a significant concern in diabetes. In this episode we discuss how best to manage the risk of developing or worsening of CKD, through factors such as blood pressure, blood lipids, lifestyle and the use of nephroprotective agents. We are joined by Dr David Cherney, whose research focuses on the development of renal disease in diabetes. Dr Cherney is Associate Professor in the Department of Medicine, University of Toronto and a Clinician Scientist at the University Health Network and Mount Sinai Hospitals, where he is director of the Renal Physiology Laboratory.

For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn.

References:

Disclosures:

Dr. David Cherney declares the following:

Grants/research support: Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi, AstraZeneca and Novo-Nordisk

Consulting, speaking honoraria: Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, BMS and Novo-Nordisk

Funding statement:

This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp & Dohme Corp and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education.